FDA inspection
Vertex Pharmaceuticals, Inc.: FDA inspection ending Sep 7, 2017
FDA inspection 1024312 · Voluntary Action Indicated (VAI) · Boston, MA
Key facts
| Inspection ID | 1024312 |
|---|---|
| Firm | Vertex Pharmaceuticals, Inc. |
| FEI number | 1000513211 |
| Address | 50 Northern Ave |
| City | Boston |
| State | MA |
| ZIP | 02210-1862 |
| Fiscal year | 2017 |
| Inspection end date | Sep 7, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data